The host-encoded Perforin-2 (encoded by the macrophage-expressed gene 1, Mpeg1), which possesses a pore-forming MACPF domain, reduces the viability of bacterial pathogens that reside within membrane-bound compartments. Here, it is shown that Perforin-2 also restricts the proliferation of the intracytosolic pathogen Listeria monocytogenes. Within a few hours of systemic infection, the massive proliferation of L. monocytogenes in Perforin-2 ؊/؊ mice leads to a rapid appearance of acute disease symptoms. We go on to show in cultured Perforin-2 ؊/؊ cells that the vacuole-to-cytosol transitioning of L. monocytogenes is greatly accelerated. Unexpectedly, we found that in Perforin-2 ؊/؊ macrophages, Listeria-containing vacuoles quickly (<15 min) acidify, and that this was coincident with greater virulence gene expression, likely accounting for the more rapid translocation of L. monocytogenes to its replicative niche in the cytosol. This hypothesis was supported by our finding that a L. monocytogenes strain expressing virulence factors at a constitutively high level replicated equally well in Perforin-2 ؉/؉ and Perforin-2 ؊/؊ macrophages. Our findings suggest that the protective role of Perforin-2 against listeriosis is based on it limiting the intracellular replication of the pathogen. This cellular activity of Perforin-2 may derive from it regulating the acidification of Listeria-containing vacuoles, thereby depriving the pathogen of favorable intracellular conditions that promote its virulence gene activity.
B
oth extracellular bacteria and virus-infected cells are targeted by innate defense responses that employ pore-forming proteins (1) . Extracellular bacteria that become bound with the complement factor C3b and the C5b-8 complex trigger the polymerization of C9, resulting in a doughnut-shaped pore with a diameter of 100 Å that constitutes the membrane attack complex (MAC) (2) (3) (4) . Similarly, virus-infected cells are recognized and eliminated by natural killer (NK) and cytotoxic T lymphocytes (CTL) that, as part of their respective killing programs, secrete Perforin-1, which forms a cluster of lethal pores in the membrane of the infected cell (5, 6) . The complement proteins C6 to C9 and Perforin-1 all possess a membrane-attack-complex-perforin (MACPF) domain, which mediates the homopolymerization process that drives pore formation.
A gene predicted to encode a third MACPF-containing protein, macrophage expressed gene-1 (Mpeg1), recently has been described in a number of invertebrates and zebrafish and plays a role in innate immune responses in these species to bacterial pathogens (7) (8) (9) (10) (11) . Phylogenic analyses indicate that the MACPF domain of Mpeg1 is the ancestor of the MACPF domains in the complement and Perforin-1 proteins (12) . Interestingly, although homologous Mpeg1 genes are found in most metazoan genomes spanning from sponges to humans, Mpeg1, or MACPF-encoding genes more generally, so far have not been identified in nonmetazoan clades of eukaryotes. However, the MACPF domain itself bears a striking structural similarity to the pore-forming domains of cholesterol-dependent cytolysins (CDCs) expressed by Grampositive bacteria, indicating the evolutionary relatedness of these pore-forming domains (13) . Owing to shared evolutionary history and functional similarities, the MACPF and CDC have been proposed to be in the same family of pore-forming proteins (14) .
We have recently shown that the mammalian MPEG1 homolog is constitutively expressed in macrophages, whereas in fibroblast-and endothelium-derived cells its expression is induced by interferons as well as infection with intracellular bacterial pathogens (15, 16) . In mice and humans the MPEG1 gene product, which is designated Perforin-2, is a 72-kDa protein possessing an MACPF domain in addition to a putative transmembrane and cytosolic domains. In cell-based infection studies, the proliferation of a number of intracellular bacterial pathogens is greatly enhanced when cellular Perforin-2 levels are reduced, suggesting that Perforin-2 targets vacuole-and plasma membrane-bound bacteria (15) . Additionally, at least one intracellular pathogen, Chlamydia trachomatis, has evolved to actively block inductive Perforin-2 expression in epithelial cells (16) . Thus, it appears that while Perforin-2 targets intracellular bacteria, it also can be targeted itself by pathogens in order to enhance their intracellular replication.
Intracellular bacterial pathogens can take one of two strategies following their internalization into the primary membrane-protected) L. monocytogenes numbers were determined at various time points thereafter by removing medium from wells and adding 1 ml distilled sterile water for 30 s and then plating the resulting dilutions on semisolid LB media to enumerate CFU. Short interfering RNA (siRNA)-mediated knockdown of Perforin-2 expression in MEFs was performed as described previously (15) . Briefly, three 19-nucleotide siRNA duplexes complementary to various regions of Mpeg1 or a scrambled siRNA control was transfected into ϳ2 ϫ 10 6 cells using Amaxa Nucleofector (Lonza). Cells then were plated into 24-well cell culture dishes at 3 ϫ 10 5 cells per well and infected as described above. Peritoneal exudate macrophages (PEMs) were isolated from Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ mice as described previously (6) and assessed for viability using Live/Dead fixable near-infrared dead cell stain (Life Technologies) and analyzed by flow cytometry using an LSRII (BD). Live cells were stained with the antibodies allophycocyanin (APC), clone M1/70 (Tonbo Bioscience), and phycoerythrin (PE)-cy7, clone BM8 (eBioscience), to measure the surface expression of the macrophage-specific markers CD11b and F4/80, respectively. Flow cytometry-derived data were analyzed by FlowJo software (TreeStar). PEMs were seeded either at low density on glass coverslips (for microscopy) or onto 24-well tissue culture dishes (5 ϫ 10 5 cells for CFU assays). Two hours following their seeding, adherent PEMs were infected as described above. Cell experiments using pHrodo (Invitrogen) were performed as described previously (24) . Briefly, macrophages were washed with phosphate-buffered saline (PBS) plus 10% fetal bovine serum (FBS) and then labeled with pHrodo at a final concentration of 10 g/ml. For the simultaneous labeling and infection experiments, bacteria were washed with PBS and reconstituted in PBS plus 10% FBS and then added to the macrophages.
Fluorescent and scanning electron microscopy. Following infections, macrophage genotypes were blinded to ensure unbiased analyses. Macrophages were fixed with 3.7% paraformaldehyde for 12 min before being washed and mounted onto precleaned glass slides. 4=,6-diamidino-2-phenylindole (DAPI) was included in the ProLong gold mounting medium (Invitrogen). An Olympus fluorescence BX61 microscope was used that was equipped with Nomarski differential interference contrast (DIC) optics, a Uplan S Apo 100ϫ objective (numeric aperture, 1.4), a Roper CoolSnap HQ camera, Sutter Lambda 10-2 excitation and emission filters, and a 175-W Xenon remote source. Intelligent Imaging Innovations Slidebook 4.01 for the Mac was used for image capture. For all cells analyzed, a series of optical Z sections (0.35 m) were imaged, and prior to analysis, individual stacks were deconvolved using the nearest-neighbor algorithm. Representative projected images were chosen to be included in the figures. ImageJ software was used to quantify the fluoresce signal per infected cell or per bacterium. The fluorescence signal was divided by the area of the cell or bacterium to generate a signal/area ratio that was termed fluorescence intensity in arbitrary units. The percentage of bacteria colocalized with pHrodo* (red-emitting pHrodo) was generated by counting Ͼ50 cells in at least three independent experiments, and the number of macrophage-associated bacteria associated with pHrodo* signal was divided by the total number of bacteria. PEMs plated and infected on coverslips were prepared for scanning electron microscopy (SEM) by being fixed with 4% paraformaldehyde and then dehydrated through a graded series of ethanol washes (10 min each of 35%, 70%, 95%, and 100%) and then treated with hexamethyldisilazane (HMDS) for 15 min. Samples were air dried and coated with an ultrathin layer of gold using a Denton Desk V sputter and etch unit and then imaged with a Joel JSM-6010LA analytic scanning electron microscope under high vacuum using a 9-kV accelerating voltage, 40 spot size, and 9-mm working distance.
RESULTS

Perforin-2
؊/؊ mice rapidly develop listeriosis following systemic infection. Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ mice were infected intravenously with 150,000 CFU L. monocytogenes, and within 12 hpi Perforin-2 Ϫ/Ϫ mice began to present symptoms of murine listeriosis (retarded movements, ruffled coats, and hunched backs) that, by 18 hpi, had developed to such a degree that it was necessary to euthanize the mice. In contrast, similarly infected Perforin-2 ϩ/ϩ mice showed absolutely no visible signs of disease and were indistinguishable in their behavior from uninfected control mice. Bacterial burdens in the livers, where bloodborne L. monocytogenes accumulates and establishes infection, of mice infected for either 3 hpi (prior to any signs of disease) or 18 hpi were analyzed to determine whether enhanced disease in Perforin-2 Ϫ/Ϫ mice was accompanied by greater proliferation of the pathogen. After 3 hpi there was a comparable level of liver colonization of Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ mice; however, during the succeeding 15 h of infection the bacterial burdens in the Perforin-2 ϩ/ϩ mice increased 8.5-fold, whereas bacterial burdens in the Perforin-2 Ϫ/Ϫ mice increased by 2,500-fold (Fig. 1A) . In a lower-dose infection (10,000 CFU) of longer duration (72 h), Perforin-2 ϩ/ϩ mice showed no outward signs of disease. In contrast, Perforin-2 Ϫ/Ϫ mice presented the typical symptoms of murine listeriosis noted above. Consistent with these differences in disease presentation, there were ϳ20-and ϳ100-fold differences in the bacterial burdens in the spleen and liver, respectively, between Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ mice (Fig. 1B) . Coincident with this accelerated infection, the Perforin-2 Ϫ/Ϫ mice had significantly higher serum levels of the inflammatory cytokines IL-6 and MCP-1/CCL2 than Perforin-2 ϩ/ϩ mice after 18 h of infection (Fig. 1C) . The levels of IFN-␥ and TNF-␣ also were elevated (but not significantly so) in Perforin-2 Ϫ/Ϫ mice compared to those in Perforin-2 ϩ/ϩ mice (Fig.  1C ). These cytokines were not at detectable levels in the serum of uninfected Perforin-2 ϩ/ϩ or Perforin-2 Ϫ/Ϫ mice. These data suggest that Perforin-2 is involved in limiting L. monocytogenes proliferation during the very earliest stages of systemic infection.
Perforin-2 limits the replication of L. monocytogenes in cells. The level of intracellular survival and replication of L. monocytogenes in cultured mammalian cells is determined by both L. mono- cytogenes-and host-encoded factors. Treating MEFs with IFN-␥ significantly limits the intracellular replication of L. monocytogenes as determined by a CFU assay ( Fig. 2A) . Recently, we showed that Perforin-2 is one of the hundreds of genes whose expression is increased in MEFs and other cells following IFN-␥ treatment (15) . To test whether Perforin-2 plays a role in limiting L. monocytogenes replication in IFN-␥-treated MEFs, Perforin-2 expression levels were reduced using siRNAs (15) . At all time points tested, there was an ϳ5-fold greater number of viable L. monocytogenes organisms recovered from Perforin-2 knockdown cells than from control cells (Fig. 2B ). This finding suggests that Perforin-2 is a key determinant among the IFN-␥-inducible repertoire of host factors that limit intracellular L. monocytogenes proliferation.
The role Perforin-2 plays in L. monocytogenes infection was tested further using MEFs and primary macrophages derived from Perforin-2 Ϫ/Ϫ mice described above. At early infection time points, Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ MEFs were infected at comparable levels, indicating that the attachment and cell invasion phases of L. monocytogenes infection are not affected by Perforin-2 (Fig. 2C) . However, at infections times greater than 3.5 h, there were considerably more viable L. monocytogenes organisms recovered from Perforin-2 Ϫ/Ϫ MEFs than from Perforin-2
MEFs. PEMs isolated from Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ mice were phenotypically similar in terms of expression levels of macrophage-specific surface markers (Fig. 3A) . Similar to MEFs, Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ PEMs initially were infected equally well, but starting at around 2 h of infection, the recovery of viable L. monocytogenes from Perforin-2 Ϫ/Ϫ macrophages exceeded that which was recovered from Perforin-2 ϩ/ϩ PEMs (Fig. 3B) . Although the infection kinetics differ between MEFs and PEMs in the foregoing assays, it is clear for both cell types that Perforin-2 plays a significant role in restricting the intracellular replication of L. monocytogenes.
Perforin-2 limits the translocation of L. monocytogenes into the cytosol. Following the invasion of the cell, L. monocytogenes briefly resides in a membrane-bound phagocytic vacuole before being released into the cytosol. Upon entry into the cytosol, the surface-exposed virulence factor ActA binds monomeric actin as well as the actin polymerization factors onto the exterior of L. monocytogenes (25) . Cytosolic L. monocytogenes initially becomes embedded within a cloud of actin, which eventually leads to the emergence of L. monocytogenes possessing actin "tails" due to the preferential polymerization at one pole of the bacterial cell. Therefore, within infected cells, vacuole-bound L. monocytogenes can readily be distinguished from cytosolic-residing L. monocytogenes by staining for actin. In examining individual cells infected with L. monocytogenes, there were substantially fewer actin-associated L. monocytogenes organisms in Perforin-2 ϩ/ϩ macrophages than Perforin-2 Ϫ/Ϫ macrophages following 3 h of infection (Fig. 4A) . Additionally, a substantial fraction of cytosolic L. monocytogenes in Perforin-2 Ϫ/Ϫ macrophages (but not Perforin-2 ϩ/ϩ macrophages) had transitioned from being embedded within actin clouds to possessing actin tails, suggesting more rapid kinetics of the L. monocytogenes infection process in the absence of Perforin-2. Ϫ/Ϫ macrophages were infected similarly both in terms of the average total number of intracellular L. monocytogenes organisms per cell (Fig. 4B ) and the fraction of those L. monocytogenes organisms associated with actin. However, between 90 and 180 min of infection, significant differences arose between the Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages in terms of both the total number of intracellular L. monocytogenes organisms per cell (2-fold greater in Perforin-2 Ϫ/Ϫ than Perforin-2 ϩ/ϩ ) (Fig. 4B ) and the fraction of actin-associated L. monocytogenes (3-fold greater in Perforin-2 Ϫ/Ϫ than Perforin-2 ϩ/ϩ macrophages) (Fig. 4C) . These data show that Perforin-2 limits the intracellular replication of L. monocytogenes by inhibiting its translocation into the cytosol. ϩ/ϩ macrophages, only a small fraction (Ͻ10%) of intracellular L. monocytogenes-actA p -GFP bacteria express detectable GFP (Fig. 5) . In contrast, in Perforin-2 Ϫ/Ϫ macrophages nearly half (45%) of L. monocytogenes-actA p -GFP bacteria express detectable amounts of GFP. Enhanced actA p activity likely accounts for the more rapid cloud-to-tail transitioning observed in Perforin-2 Ϫ/Ϫ macrophages.
Perforin-2 limits infection-induced expression of ActA and vacuole acidification. The various steps of the L. monocytogenes
Enhanced ActA expression levels in Perforin-2 Ϫ/Ϫ macrophages could be driven by more favorable conditions (for the pathogen) during the intravacuolar phase of its infection cycle. The vacuole-to-cytosol transition of L. monocytogenes is mediated in part by secreted virulence factors that become highly active at the reduced luminal pH of the primary vacuole (28, 29) . To monitor the pH of vacuoles of Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages, cells were labeled with an ϳ10-kDa dextran conjugated with a pH-sensitive rhodamine derivative (pHrodo). The acidification of this reagent leads to a linear increase in its fluorescence, starting at pH 6.8 and reaching a maximum at pH 5. When added to cells pHrodo is internalized by bulk-phase endocytosis, and as it is trafficked from early endosomal to lysosomal compartments in the perinuclear region, it becomes increasingly fluorescent due to the reduction in pH. There were no detectable differences between uninfected Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages following a 45-min labeling period, indicating that neither bulk-phase endocytosis nor endosomal acidification differs between these cells (Fig. 6A) . When Perforin-2 ϩ/ϩ macrophages were infected simultaneously with L. monocytogenes and labeled with pHrodo for 15 min, there was not a single observed L. monocytogenes organism in an acidified compartment (i.e., no colocalization of L. monocytogenes and red-emitting pHrodo) (Fig. 6B) . In striking contrast, 30% of L. monocytogenes organisms infecting Perforin-2 Ϫ/Ϫ macrophages were contained in highly acidic compartments, as indicated by the colocalization of L. monocytogenes and intense pHrodo fluorescence. This rapid (Յ15 min) and extreme acidification in Perforin-2 Ϫ/Ϫ macrophages was highly localized in individual cells such that many cells were observed which contained L. monocytogenes in both nonacidified and acidified compartments. Furthermore, the degree of acidification observed in L. monocytogenes-containing compartments of Perforin-2 Ϫ/Ϫ macrophages was entirely absent from Perforin-2 ϩ/ϩ macrophages, even after prolonged (Ն15 min) infection periods. Analyzing these early infection events by scanning electron microscopy (SEM) showed that structurally the L. monocytogenes cellular invasion process appeared similar in Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages; however, it appeared to occur more rapidly in Perforin-2 Ϫ/Ϫ macrophages, as indicated by L. monocytogenes being more highly embedded within the Perforin-2 Ϫ/Ϫ macrophage membrane than the Perforin-2 ϩ/ϩ macrophage membrane following 30 min of infection (Fig. 6C) . Together, these data indicate substantial differences in the immediate-early responses of Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages to L. monocytogenes infection and suggest that Perforin-2 Ϫ/Ϫ cells provide a more favorable environment for L. monocytogenes virulence protein expression and/or activity.
Hyperexpression of L. monocytogenes virulence factors overcomes Perforin-2-mediated intracellular growth restriction. If Perforin-2 limits intracellular L. monocytogenes replication by acting to inhibit the induction of virulence gene expression, then it would be expected that L. monocytogenes mutant strains that constitutively express high levels of virulence factors would have similar infection dynamics in Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ cells. The major transcriptional regulator of virulence gene expression in L. monocytogenes, PrfA, is itself activated posttranslationally following infection (30) . L. monocytogenes strains expressing constitutively active PrfA variants (encoded by prfA* alleles) are hypervirulent in both cell culture and animal infection models (21, 31) . Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages were infected with one such prfA* strain that expresses a PrfA containing a G145S mutation. Consistent with earlier published findings, there was much greater replication of the prfA* strain in Perforin-2 ϩ/ϩ macrophages than in the wild-type L. monocytogenes strain ( Fig. 7A) . There was also a high level of replication of the prfA* strain in Perforin-2 Ϫ/Ϫ macrophages, similar to that observed in Perforin-2 ϩ/ϩ macrophages and in contrast to wild-type L. monocytogenes, which, as shown earlier, has reduced replication in Perforin-2-expressing macrophages (Fig. 7A) . Consistent with the replication data, there was a comparable level of cytosolic invasion of the prfA* strain in Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ cells, in contrast to wild-type L. monocytogenes which, again as shown earlier, has reduced access to the cytosol in Perforin-2-expressing cells (Fig. 7B) . Although it should be noted that the overexpression of virulence genes may mask other differences between Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ cells, these data are consistent with a model that Perforin-2 limits L. monocytogenes intracellular replication by inhibiting the expression of its virulence genes.
DISCUSSION
Here, we showed that a host cell-encoded MACPF/CDC-containing protein, Perforin-2, acts to restrict both the replication of L. monocytogenes in cells and the systemic proliferation of this bacterial pathogen in the mouse. As mentioned in the introduction, L. monocytogenes employs an MACPF/CDC-containing protein of its own, LLO, to damage the vacuolar membrane to gain access to its replication niche in the cytosol. Thus, in light of the findings presented here, the outcome of the host-L. monocytogenes inter- action is largely dependent on the relative activities of these two MACPF/CDC proteins.
We provide evidence that Perforin-2 may be involved in cellular processes that impact the host-pathogen interaction. L. monocytogenes follows a well-characterized modus operandi following its internalization within the primary vacuole of the infected cell. If Perforin-2 only acted to increase the mortality of L. monocytogenes during its intravacuole transitioning to the cytosol, it would be expected that the kinetics of the cellular infection process (in terms of events per unit of time) would be similar between Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ cells. However, what was observed was that in Perforin-2 Ϫ/Ϫ cells the pace at which these events occurred, on a per-bacterium basis, was increased. These events included the emergence of L. monocytogenes from the primary vacuole, the activation of the actA promoter, and the level of actin binding and polymerization into tails. A clear indication that there are qualitative differences between Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ cells in their interaction with L. monocytogenes revealed itself when the endosomal acidification process was analyzed. After a very brief 15-min infection period, Perforin-2 Ϫ/Ϫ macrophages possessed L. monocytogenes-containing vacuoles that were highly acidic; compartments of comparable acidity were entirely absent from Perforin-2 ϩ/ϩ macrophages. This difference between Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages was observed only in L. monocytogenes-containing compartments, whereas there were no obvious differences in general endosomal trafficking between Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ macrophages. The rapid acidification of L. monocytogenes-containing vacuoles in Perforin-2 Ϫ/Ϫ macrophages almost certainly plays a role in the quickened pace of the infection process, since both the expression and activity of L. monocytogenes virulence factors are stimulated by low pH (28, 29) . In addition to the already-mentioned pH-dependent activity of the master transcription factor PrfA that directly regulates virulence gene expression (e.g., the gene promoter for actA), the membrane-disrupting activity of LLO is strongly enhanced when the pH falls below 5.5. This pH dependency differentiates LLO from other MACPF/CDC-containing toxins of Gram-positive pathogens (32) (33) (34) . Specifically, it has been shown recently that reduced pH promotes the transitioning of LLO from a prepore to pore-forming conformation (35) . The hypothesis that Perforin-2 impacts L. monocytogenes infection in cells through its effects on virulence factor activity was supported by the finding that L. monocytogenes strains expressing constitutively high levels of virulence factors had comparable infection dynamics in Perforin-2 ϩ/ϩ and Perforin-2 Ϫ/Ϫ cells. Precisely how Perforin-2 prevents the rapid acidification of L. monocytogenes-containing vacuoles remains to be determined. The pH of these compartments is controlled by both vacuolar ATPases (V-ATPases) that translocate protons into the luminal space as well as the back-flux (or leakage) of protons back into the cytosol that is mediated by various mechanisms (36) . In situ measurements of the phagosomal pH of peritoneal mouse macrophages (the same as the cells used in this study) found that under homeostatic conditions, the back-fluxing of protons reduces the phagosomal pH by a rate of 0.09/min (37) . The regulation of VATPases and proton back-fluxing is complex and is targeted by a number of intracellular pathogens (36) . Perforin-2 may inhibit the rapid reduction of pH of L. monocytogenes-containing vacuoles by negatively regulating V-ATPases and/or by promoting proton back-fluxing. What is clear is that host-encoded Perforin-2 and pathogen-encoded LLO, which both possess evolutionarily related MACPF/CDC domains, compete for dominance during the very initial stages of infection.
